In localized prostate cancer (Series 1, n = 338), PRSS2 expression in tumor cells was associated with increased tumor cell proliferation (by Ki67 expression), and with increased VEGF-A (Fig. 4B and Table 2). Here, PRSS2 is linked to neoplasm.